CA Stock MarketDetailed Quotes

MSCL Satellos Bioscience Inc

Watchlist
  • 0.970
  • +0.070+7.78%
15min DelayMarket Closed Dec 13 16:00 ET
110.19MMarket Cap-3.88P/E (TTM)

Satellos Bioscience Inc Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
12.79%5.06M
118.20%6.68M
395.50%8.26M
83.47%15.46M
176.83%6.25M
144.05%4.49M
39.04%3.06M
-21.07%1.67M
79.27%8.43M
43.47%2.26M
Selling and administrative expenses
8.08%1.69M
15.60%1.62M
228.80%2.08M
53.01%6.06M
117.05%2.47M
111.67%1.56M
49.45%1.4M
-26.01%632K
174.08%3.96M
366.73%1.14M
-General and administrative expense
8.08%1.69M
15.60%1.62M
228.80%2.08M
53.01%6.06M
117.05%2.47M
111.67%1.56M
49.45%1.4M
-26.01%632K
174.08%3.96M
366.73%1.14M
Research and development costs
19.35%3.26M
211.17%4.87M
536.44%5.94M
136.13%8.82M
251.82%3.59M
204.45%2.73M
154.20%1.57M
35.72%933K
86.36%3.73M
24.94%1.02M
Depreciation amortization depletion
50.00%3K
200.00%3K
100.00%2K
-97.92%7K
-83.33%2K
-98.18%2K
-99.07%1K
-99.06%1K
103.40%337K
-88.98%12K
-Depreciation and amortization
50.00%3K
200.00%3K
100.00%2K
-97.92%7K
-83.33%2K
-98.18%2K
-99.07%1K
-99.06%1K
103.40%337K
-88.98%12K
Other operating expenses
-42.71%110K
93.81%188K
137.00%237K
46.10%580K
117.05%191K
104.26%192K
-82.12%97K
-78.37%100K
-63.49%397K
-78.26%88K
Operating profit
-12.79%-5.06M
-118.20%-6.68M
-395.50%-8.26M
-83.47%-15.46M
-176.83%-6.25M
-144.05%-4.49M
-39.04%-3.06M
21.07%-1.67M
-79.27%-8.43M
-48.12%-2.26M
Net non-operating interest income (expenses)
-35.39%314K
159.42%358K
44,300.00%442K
1,734.92%1.16M
853.57%534K
24,200.00%486K
6,579.57%138K
-132.97%-1K
106.45%63K
106.03%56K
Non-operating interest income
-42.07%314K
43.20%358K
6,214.29%442K
2,015.87%1.33M
853.57%534K
27,000.00%542K
12,000.68%250K
130.79%7K
688.88%63K
1,077.21%56K
Non-operating interest expense
--0
--0
--0
--177K
--0
--56K
--112K
--8K
--0
--0
Other net income (expenses)
-1,104.67%-4.3M
123.91%285K
90,300.00%904K
46.41%-1.58M
71.34%-821K
790.32%428K
-3,129.21%-1.19M
112.28%1K
69.96%-2.95M
-3,760.87%-2.87M
Gain on sale of security
-139.70%-339K
123.91%285K
90,300.00%904K
-1,625.37%-1.16M
-4,205.00%-821K
1,477.42%854K
-4,229.19%-1.19M
-64.75%1K
-1,237.71%-67K
35.49%20K
Special income (charges)
-829.81%-3.96M
----
----
85.23%-426K
--0
---426K
----
----
70.53%-2.89M
-4,416.78%-2.89M
-Less:Impairment of capital assets
--3.96M
----
----
--0
--0
--0
----
----
--2.89M
----
-Less:Other special charges
----
----
----
--426K
--0
--426K
----
----
----
----
Income before tax
-153.16%-9.05M
-46.68%-6.04M
-314.71%-6.91M
-40.40%-15.89M
-29.00%-6.54M
-88.20%-3.57M
-84.01%-4.12M
21.26%-1.67M
27.01%-11.32M
-100.44%-5.07M
Income tax
0
5K
Earnings from equity interest net of tax
Net income
-153.16%-9.05M
-46.68%-6.04M
-314.71%-6.91M
-40.34%-15.89M
-28.87%-6.54M
-88.20%-3.57M
-84.01%-4.12M
21.26%-1.67M
26.98%-11.32M
-100.64%-5.07M
Net income continuous operations
-153.16%-9.05M
-46.68%-6.04M
-314.71%-6.91M
-40.34%-15.89M
-28.87%-6.54M
-88.20%-3.57M
-84.01%-4.12M
21.26%-1.67M
26.98%-11.32M
-100.64%-5.07M
Noncontrolling interests
Net income attributable to the company
-153.16%-9.05M
-46.68%-6.04M
-314.71%-6.91M
-40.34%-15.89M
-28.87%-6.54M
-88.20%-3.57M
-84.01%-4.12M
21.26%-1.67M
26.98%-11.32M
-100.64%-5.07M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-153.16%-9.05M
-46.68%-6.04M
-314.71%-6.91M
-40.34%-15.89M
-28.87%-6.54M
-88.20%-3.57M
-84.01%-4.12M
21.26%-1.67M
26.98%-11.32M
-100.64%-5.07M
Diluted earnings per share
-166.67%-0.08
0.00%-0.05
-50.00%-0.06
43.75%-0.18
53.85%-0.06
40.00%-0.03
28.57%-0.05
33.33%-0.04
50.00%-0.32
-550.00%-0.13
Basic earnings per share
-166.67%-0.08
0.00%-0.05
-50.00%-0.06
43.75%-0.18
53.85%-0.06
40.00%-0.03
28.57%-0.05
33.33%-0.04
50.00%-0.32
-550.00%-0.13
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 12.79%5.06M118.20%6.68M395.50%8.26M83.47%15.46M176.83%6.25M144.05%4.49M39.04%3.06M-21.07%1.67M79.27%8.43M43.47%2.26M
Selling and administrative expenses 8.08%1.69M15.60%1.62M228.80%2.08M53.01%6.06M117.05%2.47M111.67%1.56M49.45%1.4M-26.01%632K174.08%3.96M366.73%1.14M
-General and administrative expense 8.08%1.69M15.60%1.62M228.80%2.08M53.01%6.06M117.05%2.47M111.67%1.56M49.45%1.4M-26.01%632K174.08%3.96M366.73%1.14M
Research and development costs 19.35%3.26M211.17%4.87M536.44%5.94M136.13%8.82M251.82%3.59M204.45%2.73M154.20%1.57M35.72%933K86.36%3.73M24.94%1.02M
Depreciation amortization depletion 50.00%3K200.00%3K100.00%2K-97.92%7K-83.33%2K-98.18%2K-99.07%1K-99.06%1K103.40%337K-88.98%12K
-Depreciation and amortization 50.00%3K200.00%3K100.00%2K-97.92%7K-83.33%2K-98.18%2K-99.07%1K-99.06%1K103.40%337K-88.98%12K
Other operating expenses -42.71%110K93.81%188K137.00%237K46.10%580K117.05%191K104.26%192K-82.12%97K-78.37%100K-63.49%397K-78.26%88K
Operating profit -12.79%-5.06M-118.20%-6.68M-395.50%-8.26M-83.47%-15.46M-176.83%-6.25M-144.05%-4.49M-39.04%-3.06M21.07%-1.67M-79.27%-8.43M-48.12%-2.26M
Net non-operating interest income (expenses) -35.39%314K159.42%358K44,300.00%442K1,734.92%1.16M853.57%534K24,200.00%486K6,579.57%138K-132.97%-1K106.45%63K106.03%56K
Non-operating interest income -42.07%314K43.20%358K6,214.29%442K2,015.87%1.33M853.57%534K27,000.00%542K12,000.68%250K130.79%7K688.88%63K1,077.21%56K
Non-operating interest expense --0--0--0--177K--0--56K--112K--8K--0--0
Other net income (expenses) -1,104.67%-4.3M123.91%285K90,300.00%904K46.41%-1.58M71.34%-821K790.32%428K-3,129.21%-1.19M112.28%1K69.96%-2.95M-3,760.87%-2.87M
Gain on sale of security -139.70%-339K123.91%285K90,300.00%904K-1,625.37%-1.16M-4,205.00%-821K1,477.42%854K-4,229.19%-1.19M-64.75%1K-1,237.71%-67K35.49%20K
Special income (charges) -829.81%-3.96M--------85.23%-426K--0---426K--------70.53%-2.89M-4,416.78%-2.89M
-Less:Impairment of capital assets --3.96M----------0--0--0----------2.89M----
-Less:Other special charges --------------426K--0--426K----------------
Income before tax -153.16%-9.05M-46.68%-6.04M-314.71%-6.91M-40.40%-15.89M-29.00%-6.54M-88.20%-3.57M-84.01%-4.12M21.26%-1.67M27.01%-11.32M-100.44%-5.07M
Income tax 05K
Earnings from equity interest net of tax
Net income -153.16%-9.05M-46.68%-6.04M-314.71%-6.91M-40.34%-15.89M-28.87%-6.54M-88.20%-3.57M-84.01%-4.12M21.26%-1.67M26.98%-11.32M-100.64%-5.07M
Net income continuous operations -153.16%-9.05M-46.68%-6.04M-314.71%-6.91M-40.34%-15.89M-28.87%-6.54M-88.20%-3.57M-84.01%-4.12M21.26%-1.67M26.98%-11.32M-100.64%-5.07M
Noncontrolling interests
Net income attributable to the company -153.16%-9.05M-46.68%-6.04M-314.71%-6.91M-40.34%-15.89M-28.87%-6.54M-88.20%-3.57M-84.01%-4.12M21.26%-1.67M26.98%-11.32M-100.64%-5.07M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -153.16%-9.05M-46.68%-6.04M-314.71%-6.91M-40.34%-15.89M-28.87%-6.54M-88.20%-3.57M-84.01%-4.12M21.26%-1.67M26.98%-11.32M-100.64%-5.07M
Diluted earnings per share -166.67%-0.080.00%-0.05-50.00%-0.0643.75%-0.1853.85%-0.0640.00%-0.0328.57%-0.0533.33%-0.0450.00%-0.32-550.00%-0.13
Basic earnings per share -166.67%-0.080.00%-0.05-50.00%-0.0643.75%-0.1853.85%-0.0640.00%-0.0328.57%-0.0533.33%-0.0450.00%-0.32-550.00%-0.13
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.